Pharmaceutical Industry Information Portal

HomeTagsViatris

All posts by tag

Viatris

Viatris and Biocon Biologics launch Abevmy, oncology biosimilar, in Canada

Viatris Inc. and Biocon Biologics Ltd., a subsidiary of Biocon Ltd., announced May 19th, that Abevmy® (bevacizumab) is now available in Canada. Abevmy, co-developed...

Biocon to acquire Viatris’ biosimilars assets for up to $3.335 bln

Biocon Biologics Ltd., a subsidiary of Biocon Ltd., announced that it has entered into a definitive agreement with its partner Viatris Inc. Accordingly, Biocon...

The trial against EpiPen settled; Viatris to pay $264 million

Viatris Inc, the drugmaker formerly known as Mylan, said on Monday it had agreed to pay $264 million to resolve a class-action lawsuit alleging...
spot_img

Expert Articles

spot_img